My Cart
Search
Advanced Search
Popular Searches
hla (364)
Hla C 06 (364)
Hla C (364)
HLA G (364)
Recent Searches
dq7 (6)
one (6)
hla b2702 (364)
hla b27 (364)
Menu
Back to Home
  • News & Events

News & Events

Stay up to date with the latest product launches, promotions, and technical resources direct to your inbox.

FEATURED COLLABORATION

King's College, London

Pure Transplant Solutions Announces Collaboration with King’s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease

"This trial will determine whether patients' own regulatory T cells can be used to suppress immune memory responses against specific human leukocyte antigens (HLA), and if successful will pave the way for larger scale trials to determine if these regulatory cells can be used as therapy to prevent or minimise these problems in future."

Dr. Anthony Dorling

Professor of Transplant Inflammation and Repair, and Honorary Consultant Nephrologist at the Centre for Nephrology, Urology, and Transplantation.

LEARN MORE

News from Pure Protein

NEWS
Pure Transplant Solutions, LLC and Vall d’Hebron University Hospital Announce Research Collaboration – Developing New Technologies & Diagnostic Tools for B-Cell Monitoring in Transplant Rejection

OKLAHOMA CITY, OK, AUSTIN, TX, BARCELONA, SPAIN, February 15, 2022 – Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with Vall d’Hebron Barcelona Hospital […]

 February 15, 2022
Pure Transplant Solutions, LLC and Oxford Immunotec, Ltd. Announce Exclusive Sublicense Agreement to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury and Prevention of Organ Rejection

AUSTIN, TEXAS and OXFORD, UNITED KINGDOM, December 7, 2021 — Pure Transplant Solutions, LLC (PTS), a developer of novel HLA based transplant diagnostics, and Oxford Immunotec, Ltd. (OI), a global diagnostics company part of PerkinElmer Inc., today announce an exclusive sublicense agreement in which PTS will obtain exclusive commercial rights to issued patents protecting a novel […]

 December 07, 2021
Pure Transplant Solutions, LLC Announces Research Collaboration with the Department of Surgery at the University of Cambridge – Developing New Diagnostic Strategies to Prevent DSA-mediated Tissue Injury in Solid Organ Transplantation

OKLAHOMA CITY, OK, AUSTIN, TX, CAMBRIDGE, UNITED KINGDOM, July 21, 2021 — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with The University of […]

 July 21, 2021